SVS Ventures (543745)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Listed on NSE/BSE, providing a public market and disclosure obligations.
• ROCE, though tiny, is positive at 0.30% rather than negative.
• Market cap of ₹31 Cr is small, so a successful project can have a meaningful impact on per-share value.
• Price of ₹12.51 is about 19% below the 52-week high of ₹15.48, leaving some room for sentiment recovery.

Concerns

• Sales growth is -45.16% and profit growth is -37.50%; the latest quarter shows ₹0 Cr sales and ₹0 Cr net profit.
• P/E of 867.67 is unsustainable and reflects collapsed earnings, not future growth.
• Piotroski F-Score of 3/9 suggests weak financial health.
• No dividend and missing data on book value, debt/equity, and promoter holding leave balance-sheet risks unseen.

AI Analysis

I begin with a simple question: can this business earn a satisfactory return on capital? SVS Ventures answers with a ROCE of just 0.30%, and in the latest quarter both sales and net profit are ₹0 Cr. Over the last year, sales have fallen 45.16% and profits are down 37.50%. That is not a franchise; it is a business in a deep freeze. The stock trades at ₹12.51 with a P/E of 867.67. When earnings are this small, a high P/E is not a sign of growth—it is a sign that the denominator has collapsed. I cannot calculate book value, debt-to-equity, or promoter holding because the data is missing. Graham taught me to demand adequate information; without a balance sheet, there is no margin of safety. The Piotroski F-score of 3/9 reinforces my caution: financial health is weak. There is no dividend, so as a minority shareholder I receive nothing while I wait. I know real estate revenue can be lumpy, with costs incurred in one period and revenue booked at delivery, but that makes it even more important to know the project pipeline and capital structure. None of that is visible. At ₹31 Cr market cap, this is a microcap speculation. The price is above the 52-week low of ₹7.36, but that only tells me the market has recently become more hopeful. Hope is not an investment thesis. In Buffett's terms, this belongs in the 'too hard' pile. I would rather pass on a possible recovery than risk capital in a business I cannot understand. Let me see real sales, real profits, and a clear statement of net assets; then I will reconsider.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer